Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Hyperthermia × Brachytherapy × Clear all

Phase

Status

Recruiting 2 Unknown 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Uterine Cervical Neoplasms 16 Prostatic Neoplasms 6 Neoplasms 2 Uveitis 1 Uveal Melanoma 1 Uterine Cervical Dysplasia 1 To Evaluate the Efficacy and Safety of Anlotinib Combined With Concurrent Chemoradiotherapy in the Treatment of Locally Advanced Cervical Cancer 1 Sarcoma 1 Salivary Gland Neoplasms 1 Precancerous Conditions 1 Papillomavirus Infections 1 Pancreatic Neoplasms 1 Obesity 1 Neurotoxicity Syndromes 1 Liver Neoplasms 1 Hyperthermia 1 Gliosarcoma 1 Glioblastoma 1 Fatigue 1 Esophageal Squamous Cell Carcinoma 1 Esophageal Neoplasms 1 Endometrial Neoplasms 1 Endometrial Endometrioid Adenocarcinoma, Variant With Squamous Differentiation 1 Endometrial Clear Cell Adenocarcinoma 1 Deglutition Disorders 1 Choroid Neoplasms 1 Central Nervous System Neoplasms 1 Breast Neoplasms 1 Brain Neoplasms 1 Adenocarcinoma Of Esophagus 1

Interventions

Diathermy 6 Radiotherapy 2 Radiation 2 Drug Therapy 2 Cisplatin 2 Radiation Dose Hypofractionation 1 Mitomycin 1 Immune Checkpoint Inhibitors 1 Gemcitabine 1 Fluorouracil 1 Doxorubicin 1 Docetaxel 1 Cyclophosphamide 1 Chemoradiotherapy 1 Capecitabine 1 Brachytherapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03332069 2017-11-07

mEHT

University of Witwatersrand, South Africa

Phase 3 Unknown

Hyperthermia, Uterine Cervical Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡